PDB-6kax: X-ray structure of human PPARalpha ligand binding domain-intrinsic fatty acid (E. coli origin) co-crystals obtained by cross-seeding Method: X-RAY DIFFRACTION / Resolution: 1.23 Å
PDB-6kay: X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by soaking Method: X-RAY DIFFRACTION / Resolution: 1.735 Å
PDB-6kaz: X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by soaking Method: X-RAY DIFFRACTION / Resolution: 1.48 Å
PDB-6kb0: X-ray structure of human PPARalpha ligand binding domain-5,8,11,14-eicosatetraynoic acid (ETYA) co-crystals obtained by soaking Method: X-RAY DIFFRACTION / Resolution: 1.35 Å
PDB-6kb1: X-ray structure of human PPARalpha ligand binding domain-tetradecylthioacetic acid (TTA) co-crystals obtained by soaking Method: X-RAY DIFFRACTION / Resolution: 1.25 Å
PDB-6kb2: X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by soaking Method: X-RAY DIFFRACTION / Resolution: 1.95 Å
PDB-6kb3: X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by delipidation and cross-seeding Method: X-RAY DIFFRACTION / Resolution: 1.45 Å
PDB-6kb4: X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by delipidation and cross-seeding Method: X-RAY DIFFRACTION / Resolution: 1.42 Å
PDB-6kb5: X-ray structure of human PPARalpha ligand binding domain-5,8,11,14-eicosatetraynoic Acid (ETYA) co-crystals obtained by delipidation and cross-seeding Method: X-RAY DIFFRACTION / Resolution: 1.95 Å
PDB-6kb6: X-ray structure of human PPARalpha ligand binding domain-tetradecylthioacetic acid (TTA) co-crystals obtained by delipidation and cross-seeding Method: X-RAY DIFFRACTION / Resolution: 1.431 Å
PDB-6kb7: X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by delipidation and cross-seeding Method: X-RAY DIFFRACTION / Resolution: 2.14 Å
PDB-6kb8: X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by cross-seeding Method: X-RAY DIFFRACTION / Resolution: 1.47 Å
PDB-6kb9: X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by cross-seeding Method: X-RAY DIFFRACTION / Resolution: 1.55 Å
PDB-6kba: X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by co-crystallization Method: X-RAY DIFFRACTION / Resolution: 1.82 Å
PDB-6kyp: X-ray structure of human PPARalpha ligand binding domain-GW9662-clofibric acid co-crystals obtained by delipidation and co-crystallization Method: X-RAY DIFFRACTION / Resolution: 2.86 Å
PDB-6l36: X-ray structure of human PPARalpha ligand binding domain-GW9662-fenofibric acid co-crystals obtained by delipidation and co-crystallization Method: X-RAY DIFFRACTION / Resolution: 3.301 Å
PDB-6l37: X-ray structure of human PPARalpha ligand binding domain-GW9662-ciprofibrate co-crystals obtained by delipidation and co-crystallization Method: X-RAY DIFFRACTION / Resolution: 2.91 Å
PDB-6l38: X-ray structure of human PPARalpha ligand binding domain-GW9662-gemfibrozil co-crystals obtained by delipidation and co-crystallization Method: X-RAY DIFFRACTION / Resolution: 2.761 Å
PDB-6lx4: X-ray structure of human PPARalpha ligand binding domain-fenofibric acid co-crystals obtained by delipidation and co-crystallization Method: X-RAY DIFFRACTION / Resolution: 2.13 Å
PDB-6lx5: X-ray structure of human PPARalpha ligand binding domain-ciprofibrate co-crystals obtained by delipidation and co-crystallization Method: X-RAY DIFFRACTION / Resolution: 1.87 Å
PDB-6lx6: X-ray structure of human PPARalpha ligand binding domain-palmitic acid co-crystals obtained by delipidation and cross-seeding Method: X-RAY DIFFRACTION / Resolution: 1.3 Å
PDB-6lx7: X-ray structure of human PPARalpha ligand binding domain-stearic acid co-crystals obtained by delipidation and cross-seeding Method: X-RAY DIFFRACTION / Resolution: 1.41 Å
PDB-6lx8: X-ray structure of human PPARalpha ligand binding domain-oleic acid co-crystals obtained by delipidation and cross-seeding Method: X-RAY DIFFRACTION / Resolution: 1.54 Å
PDB-6lx9: X-ray structure of human PPARalpha ligand binding domain-arachidonic acid co-crystals obtained by delipidation and cross-seeding Method: X-RAY DIFFRACTION / Resolution: 1.4 Å
PDB-6lxa: X-ray structure of human PPARalpha ligand binding domain-eicosapentaenoic acid (EPA) co-crystals obtained by delipidation and cross-seeding Method: X-RAY DIFFRACTION / Resolution: 1.23 Å
PDB-6lxb: X-ray structure of human PPARalpha ligand binding domain-saroglitazar co-crystals obtained by soaking Method: X-RAY DIFFRACTION / Resolution: 2.36 Å
PDB-6lxc: X-ray structure of human PPARalpha ligand binding domain-saroglitazar co-crystals obtained by delipidation and cross-seeding Method: X-RAY DIFFRACTION / Resolution: 2.03 Å
PDB-7bpy: X-ray structure of human PPARalpha ligand binding domain-clofibric acid-SRC1 coactivator peptide co-crystals obtained by delipidation and co-crystallization Method: X-RAY DIFFRACTION / Resolution: 2.09 Å
PDB-7bpz: X-ray structure of human PPARalpha ligand binding domain-bezafibrate-SRC1 coactivator peptide co-crystals obtained by soaking Method: X-RAY DIFFRACTION / Resolution: 2.43 Å
PDB-7bq0: X-ray structure of human PPARalpha ligand binding domain-fenofibric acid-SRC1 coactivator peptide co-crystals obtained by delipidation and co-crystallization Method: X-RAY DIFFRACTION / Resolution: 1.771 Å
PDB-7bq1: X-ray structure of human PPARalpha ligand binding domain-intrinsic fatty acid (E. coli origin)-SRC1 coactivator peptide co-crystals obtained by co-crystallization Method: X-RAY DIFFRACTION / Resolution: 1.521 Å
PDB-7bq2: X-ray structure of human PPARalpha ligand binding domain-pemafibrate-SRC1 coactivator peptide co-crystals obtained by soaking Method: X-RAY DIFFRACTION / Resolution: 1.52 Å
PDB-7bq3: X-ray structure of human PPARalpha ligand binding domain-GW7647-SRC1 coactivator peptide co-crystals obtained by delipidation and co-crystallization Method: X-RAY DIFFRACTION / Resolution: 1.98 Å
PDB-7bq4: X-ray structure of human PPARalpha ligand binding domain-eicosapentaenoic acid (EPA)-SRC1 coactivator peptide co-crystals obtained by delipidation and co-crystallization Method: X-RAY DIFFRACTION / Resolution: 1.62 Å
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator